Literature DB >> 22855393

Activation-induced FoxP3 expression regulates cytokine production in conventional T cells stimulated with autologous dendritic cells.

Derek J Cavatorta1, Hollis N Erb, M Julia Felippe.   

Abstract

A defining feature of dendritic cells (DCs) is their ability to induce the proliferation of autologous T cells in the absence of foreign antigen-a process termed the "autologous mixed leukocyte reaction" (AMLR). We report that equine monocyte-derived DCs, but not macrophages, are potent inducers of the AMLR. The response is contact dependent and major histocompatibility complex class II dependent and primarily involves CD3(+) CD4(+) CD8(-) T cells. Upon stimulation with DCs or the mitogen concanavalin A, a subset of the proliferating T cells expresses the regulatory T-cell (Treg) transcription factor FoxP3. Although many of these FoxP3(+) T cells are capable of producing the effector cytokines interleukin-4 (IL-4) and gamma interferon (IFN-γ), they are more likely to produce IL-10 and less likely to produce IFN-γ than equivalent FoxP3(-) cells. Therefore, FoxP3 expression is an inherent component of equine T cell activation and is associated with a more immunosuppressive cytokine profile. These results confirm that FoxP3 expression in the horse, in contrast to the mouse, is regulated similarly to FOXP3 expression in humans and provide evidence that FoxP3 expression by conventional T cells may help regulate the developing immune response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855393      PMCID: PMC3485884          DOI: 10.1128/CVI.00308-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  58 in total

Review 1.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

2.  Transient regulatory T-cells: a state attained by all activated human T-cells.

Authors:  Vinodh Pillai; Sterling B Ortega; C K Wang; Nitin J Karandikar
Journal:  Clin Immunol       Date:  2006-12-19       Impact factor: 3.969

3.  Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.

Authors:  Angela M Thornton; Patricia E Korty; Dat Q Tran; Elizabeth A Wohlfert; Patrick E Murray; Yasmine Belkaid; Ethan M Shevach
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

4.  Phenotypic and functional characterization of a CD4(+) CD25(high) FOXP3(high) regulatory T-cell population in the dog.

Authors:  Dammy Pinheiro; Yogesh Singh; Charlotte R Grant; Richard C Appleton; Flavio Sacchini; Kate R L Walker; Alden H Chadbourne; Charlotte A Palmer; Elizabeth Armitage-Chan; Ian Thompson; Lina Williamson; Fiona Cunningham; Oliver A Garden
Journal:  Immunology       Date:  2010-09-30       Impact factor: 7.397

5.  Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets.

Authors:  C C Breathnach; G Soboll; M Suresh; D P Lunn
Journal:  Vet Immunol Immunopathol       Date:  2005-02-10       Impact factor: 2.046

6.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Anti-alpha chain monoclonal antibodies of equine MHC class-II antigens: applications to equine infectious anaemia.

Authors:  S Bendali-Ahcène; J L Cadore; M Fontaine; J C Monier
Journal:  Res Vet Sci       Date:  1997 Mar-Apr       Impact factor: 2.534

8.  Equine T-lymphocyte MHC II expression: variation with age and subset.

Authors:  D P Lunn; M A Holmes; W P Duffus
Journal:  Vet Immunol Immunopathol       Date:  1993-01       Impact factor: 2.046

9.  Activation of suppressor T cells in human autologous mixed lymphocyte culture.

Authors:  J B Smith; R P Knowlton
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

10.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

View more
  6 in total

1.  TGF-beta/atRA-induced Tregs express a selected set of microRNAs involved in the repression of transcripts related to Th17 differentiation.

Authors:  Josiane Lilian Dos Santos Schiavinato; Rodrigo Haddad; Felipe Saldanha-Araujo; João Baiochi; Amélia Goes Araujo; Priscila Santos Scheucher; Dimas Tadeu Covas; Marco Antonio Zago; Rodrigo Alexandre Panepucci
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

2.  Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.

Authors:  Laurel K Saldinger; Seldy G Nelson; Rebecca R Bellone; Mary Lassaline; Maura Mack; Naomi J Walker; Dori L Borjesson
Journal:  Vet Ophthalmol       Date:  2019-08-22       Impact factor: 1.644

Review 3.  Using CRISPR to enhance T cell effector function for therapeutic applications.

Authors:  Julian J Freen-van Heeren
Journal:  Cytokine X       Date:  2020-12-21

4.  Melatonin administration provokes the activity of dendritic reticular cells in the seminal vesicle of Soay ram during the non-breeding season.

Authors:  Hanan H Abd-Elhafeez; A H S Hassan; Manal T Hussein
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

5.  CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro.

Authors:  Farid Ghorbaninezhad; Javad Masoumi; Mohammad Bakhshivand; Amir Baghbanzadeh; Ahad Mokhtarzadeh; Tohid Kazemi; Leili Aghebati-Maleki; Siamak Sandoghchian Shotorbani; Mahdi Jafarlou; Oronzo Brunetti; Mariacarmela Santarpia; Behzad Baradaran; Nicola Silvestris
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

6.  Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.

Authors:  Jennifer M Cassano; Lauren V Schnabel; Margaret B Goodale; Lisa A Fortier
Journal:  Stem Cell Res Ther       Date:  2018-04-03       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.